Afuco™ Anti-Human VIPR1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-VIPR1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies to the VPAC1 receptor protein are used for prevention or treatment of thrombocytopenia.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-637CL |
| Pricing | Inquiry |
| Host | Human |
| Target | VIPR1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |